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I N T RODUC T I ON
Growth hormone secretagogue receptor type 1a (GH-
SR1a) is a G protein–coupled receptor (GPCR) highly 
expressed in the hypothalamus (Zigman et al., 2006). 
Ghrelin, the natural GHSR1a agonist, is a potent growth 
hormone secretagogue, and it is the only known orexi-
genic peptide hormone (Nakazato et al., 2001). Ghrelin-
induced GHSR1a activation in soma and dendrites 
regulates gene transcription and increases electrical ac-
tivity in neurons (Nakazato et al., 2001; Cowley et al., 
2003; Diano et al., 2006; Andrews et al., 2008; Shi et al., 
2013; Ribeiro et al., 2014). In addition, GHSR1a activa-
tion modulates neurotransmitter release at presynaptic 
terminals (Cowley et al., 2003; Cui et al., 2011; Yang et al., 
2011). The modulation of presynaptic voltage-gated cal-
cium channels (CaV2.1 and CaV2.2) is a well-established 
mechanism by which GPCRs regulate neurotransmitter 
release at central synapses (Catterall and Few, 2008; 
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Zamponi and Currie, 2013). However, the potential role 
of GHSR1a regulating CaV2 channels has not been tested.
GHSR1a displays two uncommon features: a high con-
stitutive activity and multiple signaling cascades that 
greatly increase the complexity of this receptor’s func-
tion. Constitutive GHSR1a activity is 50% of the maxi-
mum activity triggered by saturating concentrations of 
ghrelin (Holst et al., 2003), and it is proposed to con-
tribute to the physiological roles of the ghrelin–GHSR1a 
system (Petersen et al., 2009). However, the mecha-
nisms by which constitutive GHSR1a activity regulates 
neuronal activity in hypothalamic neurons remain poorly 
understood. On the other hand, despite the fact that it 
is well known that GHSR1a activates Gq proteins (Howard 
et al., 1996; Holst et al., 2003), recent reports indicate 
that other G proteins, such as Gi/o and G12/13, as well as 
G protein–independent pathways, such as -arrestin re-
cruitment, can mediate GHSR1a actions (Bennett et al., 
2009; Evron et al., 2014).
Here, we used a combination of genetic and pharma-
cological manipulations of GHSR1a activity to show that 
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The growth hormone secretagogue receptor type 1a (GHSR1a) has the highest known constitutive activity of any 
G protein–coupled receptor (GPCR). GHSR1a mediates the action of the hormone ghrelin, and its activation in-
creases transcriptional and electrical activity in hypothalamic neurons. Although GHSR1a is present at GABAergic 
presynaptic terminals, its effect on neurotransmitter release remains unclear. The activities of the voltage-gated 
calcium channels, CaV2.1 and CaV2.2, which mediate neurotransmitter release at presynaptic terminals, are modu-
lated by many GPCRs. Here, we show that both constitutive and agonist-dependent GHSR1a activity elicit a strong 
impairment of CaV2.1 and CaV2.2 currents in rat and mouse hypothalamic neurons and in a heterologous expres-
sion system. Constitutive GHSR1a activity reduces CaV2 currents by a Gi/o-dependent mechanism that involves 
persistent reduction in channel density at the plasma membrane, whereas ghrelin-dependent GHSR1a inhibition 
is reversible and involves altered CaV2 gating via a Gq-dependent pathway. Thus, GHSR1a differentially inhibits 
CaV2 channels by Gi/o or Gq protein pathways depending on its mode of activation. Moreover, we present evidence 
suggesting that GHSR1a-mediated inhibition of CaV2 attenuates GABA release in hypothalamic neurons, a mecha-
nism that could contribute to neuronal activation through the disinhibition of postsynaptic neurons.
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Rat neuron transfections
At the sixth day in culture, we transfected rat neurons with GH-
SR1a-YFP–, GHSR1a-A204E-YFP–, or eGFP-containing plasmids 
using a calcium phosphate technique (Jiang and Chen, 2006). 
We performed patch-clamp recordings on green fluorescent and 
nongreen neurons after 48 h in culture.
Human embryonic kidney (HEK) 293T cell culture  
and transfection
For patch-clamp experiments, we cotransfected 80% confluent 
HEK 293T cells with GHSR1a or GHSR1a-A204E and CaV2.1 
(GenBank accession no. AY714490) or CaV2.2 (GenBank accession 
no. AF055477), and the calcium channel auxiliary subunits CaV21 
(GenBank accession no. AF286488) and CaV3 (GenBank acces-
sion no. M88751) or CaV2a (GenBank accession no. M80545) in a 
1:1:1:1 molar ratio using Lipofectamine 2000 (Invitrogen). Also, 
for GHSR1a constitutive activity studies, we decreased the amount 
of GHSR1a cDNA transfected as indicated in the Results. For some 
experiments, we cotransfected empty pcDNA3.1(+), the C-terminal 
GPCR kinase 2 (MAS-GRK2-ct) (Kammermeier and Ikeda, 1999; 
Raingo et al., 2007) or a Gq dominant-negative mutant (Gq-
Q209L/D277N; Missouri S&T cDNA Resource Center, Rolla, MO). 
For imaging experiments, we replaced CaV2.1 and CaV2.2 with 
these proteins tagged with GFP. GHSR1a and GHSR1a-A204E 
clones were provided by J. Marie (Université de Montpellier, Mont-
pellier, France). Untagged CaV clones used for this study were pro-
vided by D. Lipscombe (Brown University, Providence, RI), and 
CaV2.1-GFP was provided by E.S. Piedras-Renteria (Loyola Univer-
sity Chicago, Chicago, IL).
Fluorescein-ghrelin (F-ghrelin) binding
We transfected HEK 293T cells with 0.15 or 0.6 µg GHSR1a or 
0.6 µg of empty pcDNA3.1+ plasmid as a control. We incubated the 
cells with 0.4 mM F-ghrelin (McGirr et al., 2011) in binding buffer 
(50 mM HEPES, pH 7.4, 5 mM MgCl2, 1 mM CaCl2, and 0.2% BSA, 
passed through a 0.45-µm filter). After 30 min, we washed the cells 
with PBS, fixed them with 4% formaldehyde, and covered them 
with mounting media. We observed the cells with a microscope 
(Eclipse 50i; Nikon) with a 500-nm filter. We took photomicro-
graphs with a camera (DS-Ri1; Nikon) and analyzed the photomi-
crographs with ImageJ software (1.48v).
Electrophysiology
We recorded ionic currents with an amplifier (Axopatch 200; 
Molecular Devices). We sampled data at 20 kHz and filtered it at 
10 kHz (3 dB) using pClamp8.2 software (Molecular Devices). 
We used recording electrodes with resistances between 2 and 4 MΩ 
when filled with internal solution. We admitted series resistances 
of <6 M and compensated 80% with a 10-µs lag time. We sub-
tracted current leak online using a P/4 protocol (except for the 
measure of evoked and miniature postsynaptic currents). We per-
formed all recordings at room temperature.
Sodium and barium currents of primary neuronal cultures. We 
patch-clamped 7–10 d in vitro rat- and mouse-cultured neurons 
in voltage-clamp whole-cell mode. Internal pipette solution con-
tained (mM): 134 CsCl, 10 EGTA, 1 EDTA, 10 HEPES, and 
4 MgATP, pH 7.2 with CsOH. We measured sodium currents with 
high sodium external solution containing (mM): 135 NaCl, 
4.7 KCl, 1.2 MgCl2, 2.5 CaCl2, 10 HEPES, and 10 glucose, pH 7.4 
with NaOH. To measure CaV currents, we replaced the external 
solution by a high barium solution with the neurons clamped 
at negative potentials. High barium solution contained (mM): 
10 BaCl2, 110 choline chloride, 20 tetraethyl-ammonium chlo-
ride, 1 MgCl2, 10 HEPES, 10 glucose, and 0.001 tetrodotoxin 
(TTX; Sigma-Aldrich), pH 7.4 with CsOH. We held neurons 
both constitutive and ghrelin-dependent GHSR1a ac-
tivities inhibit CaV2.1 and CaV2.2. We found fundamen-
tal differences in the mechanisms of CaV2 inhibition by 
constitutive and agonist-dependent modes of GHSR1a 
activation, including the signaling cascades involved 
and the fact that constitutive activity reduces membrane 
channel protein levels. Moreover, we found that GHSR1a 
impairs GABA release in hypothalamic neurons. Based 
on our data, we propose that this GHSR1a-depedent reg-
ulation of CaV2 could modify presynaptic function in the 
hypothalamus, particularly under fasting, when GHSR1a 
expression is increased.
MAT E R I A L S  AND  M E THOD S
Animals
Sprague-Dawley rats and GHSR-eGFP reporter mice (STOCK 
Tg(Ghsr-EGFP)KZ65Gsat/Mmucd; 030942-UCD; Mouse Mutant 
Regional Resource Center, University of California, Davis, Davis, 
CA) were bred at the animal facility of the Instituto Multidiscipli-
nario de Biología Celular (IMBICE). We housed the animals in a 
12-h light–dark cycle in a climate-controlled room (22°C) with ad 
libitum access to water and food, except when indicated. We per-
formed this study in strict accordance with the recommendations 
of the Guide for the Care and Use of Laboratory Animals of the 
National Research Council, and all efforts were made to minimize 
suffering. All experimentation received approval from the Institu-
tional Animal Care and Use Committee of the IMBICE. GHSR-
eGFP reporter mice were provided by J. Zigman (University of 
Texas Southwestern Medical Center, Dallas, TX). 
Rat neuronal primary cultures
Neuronal cultures were obtained from Sprague-Dawley rats at 
embryonic days 16–17. The procedure protocol was similar to the 
one described in Raingo et al. (2012). In brief, we anesthetized 
pregnant rats with chloral hydrate (500 mg/kg) and removed the 
embryos. We exposed the embryo brains and placed them on the 
dorsal face to remove the hypothalamus with forceps. We placed 
the blocks of tissue in sterile Hanks’ solution, and, after two washes, 
we dissociated the cells at 37°C for 20 min with Hanks’ solution 
containing 0.25 mg/ml trypsin (Microvet) and 0.28 mg/ml de-
oxyribonuclease I from bovine pancreas (Sigma-Aldrich). Next, 
we added 300 µl FBS (Internegocios) to stop the enzyme digestion. 
We mechanically dissociated the cells using several glass pipettes 
with consecutive smaller-tip diameters. We plated 70,000 cells on 
12-mm diameter glass coverslips treated previously with poly-l-
lysine (Sigma-Aldrich) and laid over 24-well plates. We incu-
bated the cells at 37°C in a 95% air and 5% CO2 atmosphere with 
Dulbecco’s modified Eagle’s medium (Microvet)/F12 1:1 me-
dium supplemented with 10% FBS, 0.25% glucose, 2 mM glu-
tamine (Gibco), 3.3 µg/ml insulin (Novo Nordisk Pharmaceutical 
Industries, Inc.), 5 U/ml penicillin G sodium salt (Richet), 5 µg/ml 
streptomycin (Richet), 40 µg/ml gentamicin sulfate salt (Richet), 
and 1% vitamin solution (Microvet). On the fourth day in culture, 
we replaced half of the incubation medium with fresh medium 
containing cytosine -d-arabinofuranoside (Sigma-Aldrich) to reach 
a final concentration of 5 µM.
Mouse neuronal primary cultures
We used GHSR-eGFP reporter mice at embryonic days 16–17. 
The procedure protocol was similar to the one described above. 
The culture conditions were the same except for the addition of 
B27 supplement (1:50; Gibco) to the incubation medium.
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membrane protein using a membrane protein extraction kit 
(BioVision) as reported elsewhere (Gandini et al., 2014). For each 
condition, we used six 100-mm culture plates of HEK 293T cells 
expressing CaV channels. We determined cytosolic and plasma 
membrane protein concentration using the bicinchoninic acid 
assay. In brief, 40/50 µg of protein samples were boiled for 5 min 
in protein-loading buffer (1.7% SDS, 0.1 M 2-mercaptoethanol, 
5% glycerol, 58 mM Tris-Cl, and 0.002% bromophenol blue, pH 6.8), 
resolved in 7% SDS-polyacrylamide gels, and transferred to nitro-
cellulose membranes (Immobilon; EMD Millipore). After block-
ing with 5% nonfat dry milk in Tris-buffered saline Tween 20 
(TBST; 100 mM Tris-Cl, 0.9% [wt/vol] NaCl, and 0.2% Tween 20, 
pH 7.5), we incubated membranes overnight with primary anti-
bodies: anti-CaV2.1 (1:300 in TBST 2.5% milk; Alomone Labs), 
anti-CaV2.2 (1:200 in TBST; EMD Millipore), anti-cadherin (1:200 
in TBST; Invitrogen), anti-AKT (1:15,000 in TBST; Santa Cruz 
Biotechnology, Inc.), and anti-Hsp90 (1:2,000 in TBST; Cell Sig-
naling Technology). Next, we washed membranes and incubated 
them with horseradish peroxidase (HRP)- conjugated secondary 
antibodies (anti–rabbit HRP; 1:5,000 in TBST; Jackson Inmuno-
Research Laboratories, Inc.; anti–mouse HRP; 1:5,000 in TBST; 
Jackson InmunoResearch Laboratories) diluted in TBST-5% non-
fat dry milk. For semiquantitative analysis, we normalized CaV chan-
nel signal to the cadherin signal. We used ImageJ software (National 
Institutes of Health) for densitometry analysis.
Ex vivo determination of [3H]GABA release in arcuate 
nucleus (ARC)
We euthanized ad libitum–fed and 48 h–fasted mice by live de-
capitation. We extracted brains, placed them briefly in cold PBS, 
and sectioned them into 1-mm coronal slices by using a stainless 
steel mouse brain matrix. We excised small punches of tissue cor-
responding to the known location of the ARC, as compared with 
the mouse brain atlas (Paxinos and Franklin, 2001), using a 15-
gauge needle. We incubated the ARC microdissections on Krebs-
Ringer bicarbonate buffer (KRBB) saturated with 95% O2 and 5% 
CO2 for 10 min at 37°C. Next, we incubated with [3H]GABA (367 
cpm/ml, with a specific activity of 92.1 Ci/mmol; PerkinElmer) in 
KRBB for 20 min to fill synaptic vesicles with the tracer, and we 
performed two washes with KRBB. After that, we incubated ARC 
microdissections for 10 min with fresh KRBB containing 56 mM 
KCl. Finally, we collected the medium, mixed it with 150 µl scin-
tillator (Ecolite), and measured the radioactivity in a -counter 
(Tracor Analytic).
Quantitative real-time (qRT)-PCR analysis
We euthanized ad libitum–fed and 48 h–fasted mice by live de-
capitation. We extracted brains, placed them briefly in cold 
diethylpyrocarbonate-PBS, and excised small punches of tissue 
corresponding to the ARC, as explained above. We then performed 
qRT-PCR analysis as described in Chuang et al. (2011a). In brief, we 
isolated total RNA from these punches using RNA STAT-60 (Tel-
Test, Inc.). We treated the RNA with RNase-free DNase (Roche) 
and reverse-transcribed it into cDNA with SuperScript II reagents 
(Invitrogen). We performed a quantitative PCR using a sequence 
detection system (7900HT; Applied Biosystems) and SYBR green 
chemistry (Applied Biosystems). Primers were mGHSR-QF1, 
5-ACCGTGATGGTATGGGTGTCG-3, and mGHSR-QR1, 5-CAC-
AGTGAGGCAGAAGACCG-3; they amplified a product within 
exon 2 of the ghsr gene. We confirmed these results by a second set 
of specific primers, one of which is located in exon 1 of the ghsr 
gene (mGHSR-QF3, 5-ATCTCCAGTGCCAGGCACTGCT-3) and 
the other of which is located in exon 2 (mGHSR-GR3, 5-AAT-
GGGCGCGAGCAGCAGGAA-3) of the ghsr gene. The mRNA rel-
ative levels were expressed relative to the housekeeping gene 36B4 
and calculated by the comparative threshold cycle (Ct) method 
at 80 mV and applied test pulses to 0 mV for 20 ms every 10 s. 
I-V protocol: we applied increasing square test pulses of 20-ms 
duration ranging from 60 to 50 mV every 5 s (Raingo et al., 2007).
Postsynaptic currents of primary neuronal cultures. We patch-
clamped 10–17 d in vitro mouse neurons. Internal pipette solu-
tion contained (mM): 115 Cs-methanesulfonate, 10 CsCl, 5 NaCl, 
10 HEPES, 20 tetraethylammonium chloride, 4 Mg-ATP, 0.3 
NaGTP, 0.6 EGTA, and 10 lidocaine N-ethyl bromide, pH 7.2 with 
CsOH. The external solution used was the high sodium solution 
described above, containing 10 µM 6-cyano-7-nitroquinoxaline-
2,3-dione (Alomone Labs) to isolate inhibitory postsynaptic cur-
rents (IPSCs). To elicit evoked responses, we delivered electrical 
stimulation through parallel platinum electrodes (1-ms duration; 
amplitude, 20 mA) while neurons were held at 80 mV. We 
added 1 µM TTX to record miniature IPSCs (mIPSCs).
Calcium currents of transiently transfected HEK 293T cells. We 
performed whole-cell patch-clamp recordings on transfected HEK 
293T cells. The internal solution was the same as that described for 
sodium and barium currents. External solution contained (mM): 
2 CaCl2, 140 choline chloride, 1 MgCl2, 10 HEPES, pH 7.4 with 
CsOH. Test pulses protocol: we applied square pulses from 100 
to 10 mV for 15 or 20 ms every 10 s. Prepulse protocol: we applied 
a prepulse of 15 ms at 80 mV 12.5 ms before the test pulse to effec-
tively remove all voltage-dependent inhibition of CaV (Raingo et al., 
2007; Lopez Soto and Raingo, 2012). This protocol has no effect 
on both CaV2.1 and CaV2.2 control current densities (CaV2.1 cur-
rents without prepulse = 54.60 ± 16.97 pA/pF vs. with prepulse = 
54.27 ± 16.92 pA/pF; n = 13; P > 0.05; and CaV2.2 currents with-
out prepulse = 46.28 ± 14.53 pA/pF vs. with prepulse = 45.38 ± 
14.23 pA/pF; n = 8; P > 0.05; paired t tests). I-V protocol: we applied 
increasing square test pulses of 20-ms duration ranging from 60 
to 50 mV every 5 s (Raingo et al., 2007).
Imaging
We transfected HEK 293T cells with CaV2.1-GFP (provided by E.S. 
Piedras-Renteria; Cao et al., 2004) or CaV2.2-GFP, both obtained 
by subcloning in pEGFP-C1 vector, its auxiliary subunits (CaV21 
and CaV3), and GHSR1a or GHSR1a-A204E as described previ-
ously. 48 or 24 h after transfection for CaV2.1-GFP or CaV2.2-GFP, 
respectively, we replaced the culture medium by 1 ml of 1 µg/ml 
of membrane marker solution (CellMask orange plasma mem-
brane stain; Molecular probes) and kept the cells at 37°C for 
1 min. Next, we washed three times with PBS. Finally, we removed 
almost all of the PBS volume and placed a clean coverslip over the 
cell layer. We obtained fluorescence photomicrographs with an 
optical fluorescence microscope (Eclipse 50i; Nikon), equipped 
with B2A and G2A filters and with a camera (DS-Ri1; Nikon). We 
performed the analysis on photomicrographs with FIJI free soft-
ware, using the CellMask red signal to mark out the plasma mem-
brane and quantify green fluorescence intensity in both the 
internal area (excluding plasma membrane) and the total area of 
each cell as integrated density. We calculated the fluorescence 
intensity corresponding to the membrane (membrane fluo-
rescence) as the difference between the fluorescence correspond-
ing to the total (total fluorescence) and the internal area. Then 
we calculated the percentage of CaV2.1-GFP or CaV2.2-GFP mem-
brane fluorescence as = (membrane fluorescence/total fluo-
rescence) × 100 for each cell.
Western blots
We used Lipofectamine Plus reagent (Invitrogen) to transfect 
HEK 293T cells with CaV2.1 or CaV2.2, the CaV channel auxiliary 
CaV21 and CaV3 subunits, as well as the GHSR1a and the 
GHSR1a-A204E or the pCDNA3.1 empty vector. We extracted 
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CaV2 subtypes, but it was more effective on CaV2.2 
compared with CaV2.1 currents (44.5 ± 6.9%, n = 8 vs. 
15.4 ± 3.9%, n = 5, respectively, at 0.6 µg of receptor 
cDNA; t test; P = 0.01). Moreover, to test if the ghrelin-
mediated effect was independent on GHSR1a expres-
sion levels and A204E mutation, we applied ghrelin in 
cells transfected with 0.15, 0.3, and 0.6 µg of GHSR1a- 
or 0.6 µg of GHSR1a-A204–containing cDNA per well 
and CaV2.1 or CaV2.2 and its auxiliary subunits. When 
0.6 µg GHSR1a cDNA was used for transfections, we 
tested the effect of ghrelin only in cells that showed a 
measurable amount of current. We found that ghrelin-
evoked GHSR1a activation inhibits CaV2.1 and CaV2.2 
independently of A204E mutation and at the same extent 
in all the GHSR1a cDNA amounts tested (Fig. 1 D).
We obtained two more sets of evidence toward two 
differential inhibitory mechanisms of constitutive and 
ghrelin-evoked GHSR1a’s effects on CaV2 currents: ghre-
lin application inhibits calcium currents in HEK 293T 
cells expressing CaV2.1 or CaV2.2 and GHSR1a in a 1:1 
molar ratio preincubated with SPA, despite the fact 
that constitutive GHSR1a activity is blocked (Fig. 2 A). 
In addition, we found that acute application of SPA 
was unable to remove CaV2 inhibition by constitutive 
GHSR1a activity (Fig. 2 B).
Thus, our data show that constitutive GHSR1a activ-
ity inhibits CaV2.1 and CaV2.2 channels by a long-term 
mechanism that depends on GHSR1a expression levels. 
In contrast, ghrelin-dependent GHSR1a activity is more 
effective to inhibit CaV2.2 as compared with CaV2.1 cur-
rents, and this inhibition is fast and independent of 
GHSR1a expression levels.
Two different signaling cascades are involved in CaV2 
inhibition by constitutive and ghrelin-dependent  
GHSR1a activities
Next, we tested the hypothesis that differential mecha-
nisms mediate the inhibition of CaV2 channels by con-
stitutive and ghrelin-dependent GHSR1a activities. We 
examined the signaling pathways engaged by GHSR1a 
that result in CaV2 inhibition. We first assessed the effec-
tiveness of ghrelin-induced activation of GHSR1a-A204E 
on CaV2.2 channels expressed in HEK 293T cells. Neither 
the Gs protein inhibitor ChTx (500 ng/ml) nor the Gi/o 
protein inhibitor PTx (500 ng/ml) affected ghrelin-me-
diated inhibition of CaV2.2 currents (Fig. 3 A). We there-
fore used a mutant form of Gq (Gq dominant-negative 
mutant [GqDN]) that acts as a dominant negative inter-
fering with Gq-dependent signaling (Yu and Simon, 1998; 
Lauckner et al., 2005), and we found that GqDN occluded 
the inhibitory actions of ghrelin on CaV2.2 (Fig. 3 A).
Then, we tested if the same G protein–signaling path-
way also mediates the inhibitory actions of constitutive 
GHSR1a activity on CaV2.2 currents independently 
of ghrelin. We found that neither GqDN nor pretreat-
ment with ChTx affects CaV2.2 current amplitude in 
(Kurrasch et al., 2004). The data are presented as a percentage of 
levels observed in wild-type ARC punches.
Drugs
We used ghrelin esterified with n-octanoic acid (Global Peptide); 
a GHSR1a inverse agonist, [d-Arg1,d-Phe5,d-Trp7,9,Leu11]–sub-
stance P (SPA; Santa Cruz Biotechnology, Inc.); the inhibitor of 
Gs protein, cholera toxin (ChTx; Sigma Aldrich); a specific in-
hibitor of Gi/o protein, pertussis toxin (PTx; Sigma-Aldrich); the 
CaV2.1 blocker, -agatoxin-IVA (Peptides International); and the 
CaV2.2 blocker, -conotoxin-GVIA (Alomone Labs).
Statistics
We analyzed and plotted the data using the OriginPro 8 (OriginLab) 
and GraphPad Prism 5 (GraphPad Software, Inc.) software. We ex-
amined the normal distribution of data by the Kolmogorov–Smirnov 
test. Based on the normality test results, we established statistical sig-
nificance (P < 0.05) by one- or two-sample t test (normal distributed 
data) or Mann–Whitney test (no normal distributed data), and mul-
tiple comparison ANOVA with Dunnett’s or Tukey’s post-test (nor-
mal distributed data) or nonparametric Kruskal–Wallis test with 
Dunn’s post-test (no normal distributed data). The specific statistical 
test used is detailed in each case. We expressed data as mean ± SE 
with the number of observations in brackets.
R E S U L T S
Constitutive and ghrelin-dependent GHSR1a activities 
differentially inhibit CaV2 currents in a heterologous 
expression system
We first examined the effect of GHSR1a and GHSR1a-
A204E, a mutant lacking constitutive activity (Pantel et al., 
2006), on cloned CaV2.1 and CaV2.2 channels. We coex-
pressed GHSR1a and CaV2 in a 1:1 molar ratio (0.6 µg 
of receptor cDNA per transfection) and measured cal-
cium currents in HEK 293T cells. Calcium currents 
were significantly smaller in cells coexpressing GHSR1a 
and CaV2, as compared with those expressing CaV2 
alone. In contrast, CaV2 currents in cells coexpressing 
GHSR1a-A204E were not different from control record-
ings. We next tested if agonist-independent GHSR1a-in-
duced inhibition of CaV2 varies with GHSR1a expression 
levels. Thus, we measured CaV2 currents in cells trans-
fected with CaV2.1 or CaV2.2 channels and different 
amounts of GHSR1a plasmid and found that CaV2 cur-
rent amplitudes were inversely proportional to GHSR1a 
cDNA amount per transfection (Fig. 1 A). Moreover, 
we found that F-ghrelin binding positively correlated 
with the level of GHSR1a cDNA used in the transfec-
tion (Fig. 1 B). Next, we measured basal CaV2 currents 
in cells expressing GHSR1a with or without preincuba-
tion with the GHSR1a inverse agonist SPA (1 µM) for 
16 h, and we found no significant difference with cur-
rents recorded in cells coexpressing GHSR1a-A204E 
(Fig. 1 C). To assess ghrelin-dependent GHSR1a ac-
tion on CaV2 currents, we used GHSR1a-A204E, which 
lacks constitutive activity but is prone to activation by 
agonist binding. The application of a saturating dose 
of ghrelin (0.5 µM; Pantel et al., 2006) inhibited both 
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coexpressing GHSR1a-A204E (Fig. 3 B). This result sug-
gests that GHSR1a inhibits CaV2.2 channels through Gi/o 
protein activation by an agonist-independent mechanism. 
cells expressing GHSR1a. In contrast, CaV2.2 currents 
in cells coexpressing GHSR1a pretreated with PTx 
were not different from the currents recorded in cells 
Figure 1. Constitutive and 
ghrelin-dependent GHSR1a activ-
ity inhibit CaV2 currents. (A) Rep-
resentative ICa traces from HEK 
293T cells transfected with CaV2.1 
or CaV2.2, CaV21, CaV3, and 
0.6 µg GHSR1a, GHSR1a-A204E, 
or empty pcDNA3.1+ (control), 
and averaged ICa at different 
amounts of GHSR1a plasmid 
transfected. (B) Representative 
microphotographs (left) and aver-
age fluorescent signal intensity 
(right) for the F-ghrelin binding 
in cells transfected with increas-
ing amounts of GHSR1a plasmid. 
(C) Representative ICa traces from 
cells cotransfected with CaV2.1 
and CaV2.2, CaV21, CaV3, and 
0.6 µg GHSR1a or GHSR1a-
A204E with or without 1 µM SPA 
preincubation (left), and the 
averaged ICa for each condition 
(right). (D) Time courses and 
representative traces of ghrelin 
effect on ICa from cells expressing 
CaV2.1 or CaV2.2, CaV21, CaV3, 
and GHSR1a-A204E (left), and 
the averaged percentage of CaV2.1 
and CaV2.2 current inhibition at 
different amounts of GHSR1a 
plasmid transfected. ANOVA with 
Dunnett’s (C) and Tukey’s post-
test (D). *, P < 0.05. Error bars 
represent mean ± SE.
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relieved by strong depolarizing prepulses (voltage sensi-
tive) (Ikeda, 1996; Raingo et al., 2007; Lipscombe et al., 
2013). On the other hand, several G protein sub-
types (Gq, Gi/o, and Gs) activate voltage-insensitive forms 
of CaV2 inhibition (Kammermeier and Ikeda, 1999; 
Kammermeier et al., 2000; Zamponi and Currie, 2013; 
Agosti et al., 2014). We found that inhibition of CaV2.2 
channels by ghrelin-induced activation of GHSR1a-
A204E is not relieved by 80-mV prepulses, consistent 
with a purely voltage-independent mechanism and a Gq-
mediated pathway (Fig. 3 D). However, it is known that 
Gq-mediated inhibition of CaV2.2 channels turns into a 
voltage-sensitive inhibition by substituting the CaV3 for 
a membrane-bound form, CaV2a (Keum et al., 2014). 
Thus, we assayed ghrelin-mediated inhibition of CaV2.2 
with CaV2a as auxiliary subunit. We found that ghre-
lin-mediated inhibition of CaV2.2 was not only reduced, 
as compared with the inhibition of CaV2.2 channels 
formed by CaV3, but also completely reversed by 80-mV 
prepulses (Fig. 3 C). Moreover, we coexpressed the 
MAS-GRK2-ct peptide to sequester G (Kammermeier 
and Ikeda, 1999; Raingo et al., 2007) and found that 
this maneuver fully occluded the inhibitory actions of 
ghrelin–GHSR1a-A204E on CaV2.2 channels coexpressed 
with either CaV2a or CaV3. Collectively, our results 
demonstrate that ghrelin-mediated GHSR1a activation 
inhibits CaV2.2 currents by a mechanism that involves 
Gq, G subunits of G proteins whose voltage dependency 
relies on the CaV subtype. On the other hand, we found 
that inhibition of CaV2.2 by constitutive GHSR1a activity 
is unaltered by strong prepulses to 80 mV, CaV subtype, 
or G sequestration (Fig. 3 E). Thus, our results suggest 
that agonist-dependent and agonist-independent forms 
of CaV2.2 inhibition by GHSR1a signal through differ-
ent pathways.
CaV2 inhibition by constitutive GHSR1a activity 
is associated with a reduced channel density  
at the plasma membrane
Based on our results showing that the GHSR1a inverse 
agonist, SPA, requires long preincubation periods to oc-
clude constitutive inhibition of CaV2 by GHSR1a, we de-
cided to test if surface CaV2 density was affected by 
constitutive GHSR1a activity. First, we monitored the 
presence of CaV2 channels in the plasma membrane, 
using CaV2.1 and CaV2.2 channels tagged with GFP 
(CaV2.1-GFP and CaV2.2-GFP) that we have confirmed 
are functional in our experimental conditions (CaV2.1-
GFP current, 47.0 ± 14.5 pA/pF, n = 9; CaV2.2-GFP 
current, 51.8 ± 12.3 pA/pF, n = 5). To identify the sur-
face location of the GFP fluorescence signal, we used 
the red fluorescent membrane marker CellMask (Cogger 
et al., 2010). We found that CaV2.1-GFP– and CaV2.2-
GFP–associated fluorescence signal was significantly 
lower in cells coexpressing GHSR1a, as compared with 
those coexpressing GHSR1a-A204E or those coexpressing 
Next, we incubated cells expressing the wild-type recep-
tor GHSR1a with PTx, and then determine whether the 
agonist still modulates channel activity. We found that 
ghrelin inhibits the currents in this experimental condi-
tion, suggesting that the agonist-mediated and constitu-
tive activity of GHSR1a modulates CaV2 channels by two 
independent pathways (Fig. 3 C).
GPCR-mediated inhibition of CaV2.2 is mediated for 
at least three different G proteins, and the downstream 
mechanisms can be voltage sensitive or voltage insensi-
tive (Zamponi and Currie, 2013). The most common 
form of Gi/o-dependent inhibition of CaV2.2 channels 
involves direct binding of G to the channel, and it is 
Figure 2. Constitutive GHSR1a activity inhibits by a long-term 
mechanism the CaV2 currents preserving CaV2 current inhibition 
by ghrelin-dependent GHSR1a activity. (A) Representative ICa 
traces (left) from HEK 293T cells expressing CaV2.1 (above) or 
CaV2.2 (below), CaV21, CaV3, and GHSR1a preincubated with 
1 µM SPA, before (control) and after (+ghrelin) 500-nM ghrelin 
application, and averaged percentage of ICa inhibition by 500 nM 
ghrelin (right) from HEK 293T cells expressing CaV2.1 or CaV2.2, 
CaV21, CaV3, and GHSR1a preincubated with 1 µM SPA or 
GHSR1a-A204E as a control condition. (B) Time courses of peak 
CaV2 currents (left) with the acute application of 1 µM SPA (gray 
bars) from HEK 293T cells expressing CaV2.1 (above) or CaV2.2 
(below), CaV21, CaV3, and GHSR1a, and the averaged CaV2.1 
or CaV2.2 currents before (control) and after (+SPA) acute ap-
plication of 1 µM SPA. Two sample (A) and paired (B) Student’s 
t tests. Error bars represent mean ± SE.
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expression of CaV2.1 and CaV2.2 channels by a Gi/o-de-
pendent mechanism.
Constitutive and ghrelin-dependent GHSR1a activities 
inhibit native N- and P/Q-type currents
To test the effect of GHSR1a activities on calcium chan-
nels in native conditions, we used hypothalamic pri-
mary neuronal cultures of GHSR-eGFP reporter mice 
in which GHSR1a-expressing neurons are identifiable 
by green fluorescent signal (Mani et al., 2014). We first 
compared CaV currents recorded in GHSR1a-positive 
(GHSR1a+) and GHSR1a-negative (GHSR1a) neurons. 
CaV currents were inhibited by 100 µM CdCl2 (percent-
age of inhibition: GHSR1a+, 99.91 ± 2.51%, n = 5; 
GHSR1a and preincubated with SPA or PTx (Fig. 4 A). 
Next, we used Western blots to confirm that the CaV2.1 
and CaV2.2 membrane protein level is decreased when 
cells coexpress GHSR1a. We used HEK 293T cells 
transfected with CaV2.1 or CaV2.2, as well as GHSR1a, 
GHSR1a-A204E, or the pcDNA3.1 empty vector. By using 
cadherin as a plasma membrane marker, and AKT and 
Hsp90 as cytoplasmic protein markers, we found that 
CaV2.1 and CaV2.2 protein quantity decreased in the 
plasma membrane protein fraction when cells coex-
press GHSR1a, whereas GHSR1a-A204E coexpression 
failed to affect the amount of CaV2.1 and CaV2.2 plasma 
membrane protein (Fig. 4 B). Collectively, our data sug-
gest that constitutive GHSR1a activity reduces surface 
Figure 3. CaV2.2 inhibition by constitutive and ghrelin-dependent GHSR1a activity is signaled by Gi/o and Gq proteins, respectively. 
(A) Time course, representative traces, and averaged ICa inhibition by 500 nM ghrelin in HEK 293T cells transfected with CaV2.2, CaV21, 
CaV3, and GHSR1a-A204E in control conditions or preincubated with 500 ng/ml ChTx or 500 ng/ml PTx, or cotransfected with a 
GqDN. (B) Representative traces and averaged ICa in HEK 293T cells expressing CaV2.2, CaV21, CaV3, and GHSR1a or GHSR1a-A204E 
in control or preincubated with 500 ng/ml ChTx or 500 ng/ml PTx, or cotransfected with GqDN. (C) Representative traces and aver-
aged ICa inhibition by 500 nM ghrelin in HEK 293T cells transfected with CaV2.2, CaV21, CaV3, and GHSR1a preincubated with 
500 ng/ml PTx. (D) Representative ICa in HEK 293T cells cotransfected with CaV2.2, CaV21, GHSR1a-A204E, and CaV3 or CaV2a without 
(control) or with (+ghrelin) 500 nM ghrelin without or with (+pp) an 80-mV prepulse application (left), and averaged percentage of 
ICa inhibition by 500 nM ghrelin in cells expressing CaV2.2, CaV21, and GHSR1a-A204E with the coexpression of CaV3 or CaV2a and 
MAS-GRK2-ct and prepulse application (+pp; right). (E) Representative ICa traces from cells cotransfected with CaV2.2, CaV21, CaV3, 
and GHSR1a or GHSR1a-A204E with (+pp) or without (Control) the application of an 80-mV prepulse (left) and averaged ICa from HEK 
293T cells expressing CaV2.2, CaV21, GHSR1a, or GHSR1a-A204E, with the coexpression of CaV3 or CaV2a and MAS-GRK2ct and an 
80-mV prepulse application (+pp; right). ANOVA with Dunnett’s (A and B) or Tukey’s post-test (D), and two-sample Student’s t test (E). 
*, P < 0.05. Error bars represent mean ± SE.
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subtypes were significantly smaller in GHSR1a+ com-
pared with GHSR1a neurons in the presence or ab-
sence of ghrelin (Fig. 5 C). However, TTX-sensitive NaV 
currents in GHSR1a+ and GHSR1a neurons were not 
different (t test; P > 0.05; Fig. 5 D). Thus, GHSR1a+ neu-
rons have reduced N- and P/Q-type currents as com-
pared with GHSR1a neurons, and ghrelin inhibits those 
currents only in GHSR1a+ neurons.
To dissociate the effect of constitutive and ghrelin-
dependent GHSR1a activities on native calcium chan-
nels, we transfected either GHSR1a-YFP or GHSR1a- 
A204E-YFP in hypothalamic rat-cultured neurons, which 
express minimal levels of endogenous GHSR1a under 
our experimental conditions (6 ± 2% of neurons bind 
F-ghrelin; n = 3 independent cultures). CaV currents 
GHSR1a, 99.28 ± 0.98%, n = 5; both NS vs. 100%; 
t test; P > 0.05). CaV currents recorded in GHSR1a+ neu-
rons displayed the same voltage dependency as those 
recorded in GHSR1a neurons, but they were signifi-
cantly smaller (Fig. 5, A and B). Importantly, ghrelin 
application inhibited CaV currents in GHSR1a+ but not 
in GHSR1a neurons (Fig. 5 A), and the effect was in-
sensitive to 80-mV prepulse application, in agreement 
with our data in the expression system (percentage of 
IBa inhibition by ghrelin without 80-mV prepulse, 28.14 ± 
6.16, and with 80-mV prepulse, 26.22 ± 7.27; NS; n = 4 
neurons; P = 0.57; paired t test). We used -conotoxin-GVIA 
and -agatoxin-IVA to quantify the contribution of 
N- (CaV2.2) and P/Q-type (CaV2.1) channels, respectively, 
in this experimental system. We found that both current 
Figure 4. GHSR1a decreases surface CaV2.1 and CaV2.2 density. (A) Photomicrographs and averaged percentages of green fluorescent 
plasma membrane signal of HEK 293T cells transfected with CaV2.1-GFP (left) and CaV2.2-GFP (right), its auxiliary subunits (Control) 
with GHSR1a or GHSR1a-A204E, and preincubated or not with 1 µM SPA or 500 ng/ml PTx. Green and red signals correspond to the 
eGFP tag on CaV2 and the membrane marker CellMask, respectively. Kruskal–Wallis with Dunn’s post-test; *, P < 0.01. (B) Western blot 
analysis displaying the CaV2.1-GFP and CaV2.2-GFP protein level in the plasma membrane (PM) or the cytoplasmic (Cyt) fraction of HEK 
293T cells transfected with CaV2.1-GFP or CaV2.2-GFP and its auxiliary subunits (Control), and cotransfected with GHSR1a or GHSR1a-
A204E (left), and averaged percentage of CaV2.1-GFP and CaV2.2-GFP PM protein level in each condition normalized against cadherin 
signal used as the plasma membrane loading control (right). Both AKT and Hsp90 as cytosolic markers. n = 2 and 3 for CaV2.1-GFP or 
CaV2.2-GFP, respectively. Error bars represent mean ± SE.
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calcium currents in the presence of ghrelin showed a re-
duced contribution of CaV2 in both GHSR1a-YFP– and 
GHSR1a-A204E-YFP–expressing neurons (Fig. 6 C). Im-
portantly, TTX-sensitive NaV currents were not affected 
among the different experimental conditions (Fig. 6 D). 
Thus, constitutive and ghrelin-dependent GHSR1a ac-
tivities inhibit native N- and P/Q-type calcium currents 
in hypothalamic neurons.
Constitutive and ghrelin-dependent GHSR1a activities 
reduce GABA release from hypothalamic explants
In previous studies, we have suggested that GHSR1a 
activity decreases inhibitory tone on hypothalamic neu-
rons (Cabral et al., 2012). Thus, we next evaluated if 
recorded in neurons expressing GHSR1a-YFP were sig-
nificantly smaller as compared with those recorded in 
either neurons expressing eGFP or GHSR1a-A204E-YFP 
neurons (Fig. 6 A). Ghrelin inhibited the same relative 
percentage of CaV currents in neurons expressing either 
GHSR1a-YFP or GHSR1a-A204E-YFP, whereas it failed to 
affect CaV currents in neurons expressing eGFP or non-
transfected neurons (Fig. 6 B; normalized current traces). 
We next used -conotoxin-GVIA and -agatoxin-IVA to 
test CaV2 subtype contribution to the total CaV current in 
our experimental conditions. We found a smaller contri-
bution of CaV2.1 and CaV2.2 in GHSR1a-YFP–expressing 
neurons as compared with the contribution found in 
GHSR1a-A204E-YFP–expressing neurons. Additionally, 
Figure 5. GHSR1a activity modulates native CaV2 currents in hypothalamic neurons from GHSR-eGFP reporter mice. (A) Represen-
tative IBa traces and averaged IBa before (control) and after (+ghrelin) 500-nM ghrelin application in hypothalamic GHSR1a and 
GHSR1a+ neurons. (B) Averaged peak IBa–voltage (I-V) relationships (evoked from a holding of 80 mV), reversal (Vrev), and activa-
tion (V1/2) potential midpoints (calculated by Boltzmann linear function) obtained from GHSR1a and GHSR1a+ neurons. (C) IBa 
time courses of application of 1 µM -conotoxin-GVIA (conoTx) and 0.2 µM -agatoxin-IVA (agaTx) with or without previous 500-nM 
ghrelin application from hypothalamic GHSR1a (top) and GHSR1a+ neurons (middle and bottom; left). Averaged percentage of IBa 
sensitive to agaTx and conoTx from GHSR1a and GHSR1a+ neurons, with (+ghrelin) or without 500-nM ghrelin application (right). 
(D) Representative and averaged INa from GHSR1a and GHSR1a+ neurons. Paired (A) or two-sample (B and D) Student’s t test and 
ANOVA with Dunnett’s post-test (C). *, P < 0.05. Error bars represent mean ± SE.
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GABA release, we recorded IPSCs in hypothalamic neu-
ronal cultures from GHSR-null mice transduced with 
either GHSR1a-YFP or GHSR1a-A204E-YFP lentiviral 
vectors, which allow a high percentage of GHSR1a-ex-
pressing neurons. In these experimental conditions, we 
found a reduced IPSC size triggered by electrical stimu-
lation in GHSR1a-YFP–expressing cultures compared 
with both GHSR1a-A204E-YFP–expressing cultures and 
nontransduced cultures (Fig. 7 B). Moreover, we found 
that acute ghrelin application reduced by 20% the 
IPSC peak in cultures expressing either GHSR1a-YFP or 
GHSR1a-A204E-YFP (Fig. 7 C; normalized IPSC record-
ings), indicating that both GHSR1a variants are func-
tional and that ghrelin-dependent GHSR1a activation 
can further inhibit IPSCs. Finally, we recorded GABAer-
gic postsynaptic responses stimulated by hyperosmotic 
solution in the presence of TTX, a maneuver known to 
release neurotransmitter in a CaV-independent manner. 
GHSR1a activity affects GABA release from explants of 
the ARC, a hypothalamic nucleus where GHSR1a is 
highly expressed (Zigman et al., 2006) and GABA re-
lease is essential for food intake regulation (Wu et al., 
2009). To explore the role of constitutive GHSR1a activ-
ity, we used 48 h–fasted mice, in which hypothalamic 
GHSR1a mRNA levels were 1.5-fold higher compared 
with levels found in ad libitum–fed mice (Fig. 7 A, 
right). We studied the [3H]GABA release from explants 
of ARC, and we found a significant reduction of [3H]
GABA release stimulated by high K+ in explants from 
fasted mice as compared with release detected in explants 
from ad libitum–fed mice (Fig. 7 A, left). Thus, our data 
show that fasting-induced increase of GHSR1a expres-
sion levels correlates with an inhibition of GABA release 
from ARC neurons.
To test if constitutive GHSR1a activity–displayed inhi-
bition of N- and P/Q-type currents has an impact on 
Figure 6. GHSR1a activity inhibits native CaV2 currents from rat hypothalamic neurons. (A) Representative and averaged IBa from 
nontransfected (nt) and GFP-, GHSR1a-YFP–, and GHSR1a-A204E-YFP–transfected neurons. (B) Normalized IBa traces before (control) 
and after (+ghrelin) 500-nM ghrelin application, and averaged percentage of IBa inhibition by ghrelin in each condition. (C) IBa time 
courses of application of 1 µM -conotoxin-GVIA (conoTx) and 0.2 µM -agatoxin-IVA (agaTx) with or without previous 500-nM ghre-
lin application from GFP-, GHSR1a-, and GHSR1a-A204E–transfected neurons (left). Averaged percentage of IBa sensitive to agaTx and 
conoTx from nontransfected (nt), GFP-, GHSR1a-, and GHSR1a-A204E–transfected neurons, with (+ghrelin) or without 500-nM ghrelin 
application (right). (D) Representative and averaged INa from nontransfected (nt) and GFP-, GHSR1a-, and GHSR1a-A204E–transfected 
neurons. ANOVA with Dunnett’s post-test (A–D). *, P < 0.05. Error bars represent mean ± SE.
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D I S C U S S I ON
We present evidence that GHSR1a, the GPCR with the 
highest constitutive activity, down-regulates CaV2.1 and 
CaV2.2 currents by a mechanism that is independent 
of its endogenous agonist, ghrelin, and involves Gi/o 
signaling and plasma membrane channel density re-
duction. We also show that ghrelin inhibits native and 
cloned CaV2.1 and CaV2.2 currents via activation of 
GHSR1a by a different signaling cascade that involves 
Gq protein activation. These two fundamentally differ-
ent mechanisms could differentially contribute to regu-
late presynaptic Ca2+ entry and transmitter release from 
hypothalamic neurons.
Presynaptic CaV2 channel inhibition by GPCRs is an 
important mechanism mediating the effects of many 
transmitters and drugs that control neurotransmitter 
release (Catterall and Few, 2008). GHSR1a is expressed 
at axonal terminals, and a presynaptic role for this re-
ceptor has been suggested (Cowley et al., 2003; Cui 
et al., 2011; Yang et al., 2011; Ribeiro et al., 2014). In 
general, the ghrelin–GHSR1a system stimulates electrical 
and transcriptional activity in neurons (Cowley et al., 2003; 
Andrews et al., 2009; Shi et al., 2013). Also, it has been 
shown that GHSR1a signaling augments cytosolic Ca2+ 
levels in hypothalamic neurons (Howard et al., 1996; 
Chuang et al., 2011b; Yang et al., 2011). Here, we propose 
a novel mechanism that could potentially contribute to 
neuronal activation of hypothalamic neurons by control-
ling CaV2 channels located at the presynaptic terminals 
of inhibitory input neurons. Moreover, in agreement with 
previous data showing that GHSR1a can couple to several 
different pathways, we demonstrate that two fundamen-
tally different mechanisms govern ghrelin-dependent 
and ghrelin-independent CaV2 inhibition by GHSR1a.
We show evidence that constitutive GHSR1a activity 
down-regulates CaV2 channel density by a Gi/o-dependent 
signaling pathway. GHSR1a is typically thought to in-
volve Gq protein activation (Holst et al., 2003), although 
Gi/o involvement is also well documented (Bennett et al., 
2009). Other GPCRs, such as the nociceptin recep tor 
(opioid receptor–like 1 [ORL1]) and metabotropic 
glutamate receptor subtype 1, have been shown to in-
hibit CaV2 by agonist-binding independent mechanisms 
that require GPCR and channel protein direct interac-
tion (Kitano et al., 2003; Beedle et al., 2004). ORL1 is a 
Gi/o-coupled receptor that inhibits CaV2.2 channels in 
dorsal root ganglion neurons, and it has been shown that 
basal and nociceptin-mediated ORL1 inhibition of CaV2.2 
shared a G-mediated pathway, as both are avoided by 
G sequestering or depolarizing prepulse voltage appli-
cation (Beedle et al., 2004). In contrast, here we show 
that CaV2 current inhibition by constitutive GHSR1a ac-
tivity differs from ghrelin-evoked effect, as the former 
mode of inhibition is independent of G binding and 
unaffected by a depolarizing prepulse.
We found no differences in these responses among 
nontransduced, GHSR1a-YFP–transduced, and GHSR1a-
A204E-YFP–transduced cultures, suggesting that con-
stitutive GHSR1a activity exclusively affects action 
potential–dependent and CaV2-mediated GABAergic 
neurotransmission. Importantly, the size of spontaneous 
IPSCs was not different among conditions (Fig. 7 D), in-
dicating the lack of postsynaptic effects in the IPSC size 
reduction by GHSR1a activity.
Figure 7. GHSR1a activity impacts GABA release. (A) [3H]
GABA release (left) and GHSR1a mRNA levels (right) from 
ARC-enriched explants from ad libitum–fed or 48 h–fasted mice. 
(B) Representative traces and averaged IPSC size obtained from 
GHSR-null primary cultured neurons transduced or not with 
GHSR1a-YFP and GHSR1a-A204E-YFP. (C) Representative nor-
malized traces with or without the application of 500 nM ghrelin, 
and average values of percentage of IPSC inhibition by ghrelin 
obtained from GHSR-null primary cultured neurons transduced 
or not with GHSR1a-YFP and GHSR1a-A204E-YFP. (D) Distribu-
tion of mIPSC size and averaged values for mIPSC frequencies 
and charge movement by 0.5-M sucrose solution application in 
GHSR-null primary cultured neurons transduced or not with 
GHSR1a-YFP and GHSR1a-A204E-YFP. Two-sample Student’s 
t test (A) and ANOVA with Dunnett’s post-test (B–D). *, P < 0.05. 
Error bars represent mean ± SE.
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subtype. Previous reports have shown the same depen-
dency of G for other GqPCR-mediated pathways (i.e., 
muscarinic type 1 and neurokinin type 1 receptors; 
Kammermeier et al., 2000). Thus, our data support the 
notion that CaV2a in the channel complex switches the 
voltage dependency of CaV2 inhibition by occluding Gq 
subunit–signaled effect and unmasks the inhibition by 
G direct binding, as recently demonstrated by Keum 
et al. (2014).
Peripheral administration of ghrelin potently increases 
food intake (Nakazato et al., 2001). Plasma ghrelin al-
most exclusively accesses the hypothalamic ARC, which 
expresses high levels of GHSR1a and is required for the 
orexigenic actions of peripheral ghrelin (Zigman et al., 
2006; Schaeffer et al., 2013; Cabral et al., 2014). GABA 
release from ARC neurons is essential for food intake 
regulation (Wu et al., 2009), and GHSR1a is found at 
presynaptic terminals (Cowley et al., 2003; Yang et al., 
2011). It has also been shown that GABA release by AgRP 
ARC neurons is required for ghrelin-induced food intake 
(Tong et al., 2008), and a ghrelin-induced reduction of 
GABA release has been proposed to mediate other hypo-
thalamic actions of the hormone (Cabral et al., 2012). 
Thus, current results showing that ghrelin-induced 
GHSR1a activity inhibits native calcium channels, im-
pairs CaV2-dependent GABA release from ARC explants, 
and modifies synaptic activity in hypothalamic neurons 
in culture offer a molecular mechanism that could medi-
ate well-established effects of ghrelin. In contrast, the 
physiological role of constitutive GHSR1a activity has 
been hard to highlight in in vivo settings. Here, we con-
firmed that GHSR1a expression level is affected by the 
energy balance conditions, and found that this change 
correlates with GABA release from ARC explants, sug-
gesting that GHSR1a constitutive activity may have func-
tional implications (Holst et al., 2003; Kim et al., 2003; 
Pantel et al., 2006; Kineman and Luque, 2007; Liu et al., 
2007). The fact that in vivo administration of the 
GHSR1a inverse agonist SPA reduces food intake and 
body weight in rats (Petersen et al., 2009), and that 
mice lacking GHSR1a exhibit a more severe phenotype 
as compared with ghrelin knockout mice, has also been 
interpreted as indications of a physiological role of 
the constitutive GHSR1a activity (Uchida et al., 2013). 
Notably, the A204E mutation has been associated with 
short stature and dominant transmission in human 
beings (Pantel et al., 2006). However, further studies 
are required to explore the physiological implications 
of the GHSR1a-related molecular events that occur in a 
ghrelin-independent fashion.
Current data open many intriguing questions includ-
ing the physiological relevance of constitutive activity at 
synapses without ghrelin availability and mechanisms that 
regulate the agonist-independent actions of GHSR1a. 
Interestingly, GHSR1a is also present in the brain areas 
distant from circumventricular organs (Zigman et al., 
The long-lasting inhibition of CaV2 currents by 
GHSR1a constitutive activity implicates channel density 
reduction at the plasma membrane. Several GPCRs, in-
cluding dopamine receptors and ORL1, use mechanisms 
involving channel internalization to impact CaV2 cur-
rents in the long term (Altier et al., 2006; Kisilevsky and 
Zamponi, 2008; Kisilevsky et al., 2008). In a clear demon-
stration of complexity in channel activity regulation by 
GPCRs, these receptors can inhibit the channels by volt-
age-dependent and voltage-independent modulation, as 
well as by cointernalization resulting from direct inter-
action between the activated receptor and the channel. 
We cannot discard the direct interaction between the 
GHSR1a and CaV2 channels in the mechanism involved 
in channel density reduction by GHSR1a constitutive ac-
tivity. If present, however, this mechanism is likely insuf-
ficient to mediate channel density reduction, as protein 
Gi/o activation is required for the effect. The molecular 
mechanism by which GHSR1a-mediated Gi/o basal activa-
tion modifies channel density is unclear with our present 
data. We postulate that a reduced channel trafficking is a 
more suitable hypothesis over channel internalization, 
given the long-term effect of the GHSR1a inverse agonist 
(see Fig. 2 B) and the particular distribution of fluo-
rescence signal from CaV2-GFP around the nucleus of 
transfected HEK 293T cells (see Fig. 4 A). More experi-
ments are required to determine the intermediate mo-
lecular players of this pathway. Thus, there is increasing 
evidence that channel-trafficking regulation from and to-
ward the plasma membrane could be universal mechan-
isms that GPCRs use to control voltage-gated calcium 
currents in neurons.
We found that ghrelin-dependent GHSR1a activity 
inhibits CaV2 channels by a rapid and reversible Gq-
dependent signaling pathway. Gq activation generally 
inhibits CaV2 in a voltage-independent manner. Several 
signaling pathways have been proposed to mediate cal-
cium channel inhibition, including PtdIns(4,5)P2 de-
pletion from plasma membrane, increase of arachidonic 
acid production, and protein kinases activation (Wu 
et al., 2002; Liu and Rittenhouse, 2003; Gamper et al., 
2004; Suh et al., 2010). The CaV2 inhibition induced by 
PtdIns(4,5)P2 depletion or arachidonic acid increment 
requires cytoplasmic subtypes of CaV (CaV3) and, as a 
consequence, both mechanisms fail to impair CaV2 cur-
rents if channels contain the membrane-anchored form 
of CaV, CaV2a (Heneghan et al., 2009; Suh et al., 2012). 
Accordingly, we found that the inhibition of CaV2.2 in-
duced by ghrelin-evoked GHSR1a activation depends 
on the type of CaV subunit. In particular, the ghrelin-
mediated CaV2.2 inhibition was significantly reduced 
and fully voltage dependent when CaV2a was present, 
whereas it was larger and voltage independent in the 
presence of CaV3. Additionally, we found that buffer-
ing G is enough to completely avoid the ghrelin-medi-
ated inhibition of CaV2.2 independently of the CaV 
 López Soto et al. 217
receptor. Mol. Pharmacol. 76:802–811. http://dx.doi.org/10.1124/
mol.109.056101
Cabral, A., O. Suescun, J.M. Zigman, and M. Perello. 2012. Ghrelin 
indirectly activates hypophysiotropic CRF neurons in rodents. 
PLoS ONE. 7:e31462. http://dx.doi.org/10.1371/journal.pone
.0031462
Cabral, A., G. Fernandez, and M. Perello. 2013. Analysis of brain 
nuclei accessible to ghrelin present in the cerebrospinal fluid. 
Neuroscience. 253:406–415. http://dx.doi.org/10.1016/j.neuroscience
.2013.09.008
Cabral, A., S. Valdivia, G. Fernandez, M. Reynaldo, and M. Perello. 
2014. Divergent neuronal circuitries underlying acute orexigenic 
effects of peripheral or central ghrelin: Critical role of brain ac-
cessibility. J. Neuroendocrinol. 26:542–554. http://dx.doi.org/
10.1111/jne.12168
Cao, Y.Q., E.S. Piedras-Rentería, G.B. Smith, G. Chen, N.C. Harata, 
and R.W. Tsien. 2004. Presynaptic Ca2+ channels compete for 
channel type-preferring slots in altered neurotransmission aris-
ing from Ca2+ channelopathy. Neuron. 43:387–400. http://dx.doi
.org/10.1016/j.neuron.2004.07.014
Catterall, W.A., and A.P. Few. 2008. Calcium channel regulation and 
presynaptic plasticity. Neuron. 59:882–901. http://dx.doi.org/
10.1016/j.neuron.2008.09.005
Chuang, J.C., M. Perello, I. Sakata, S. Osborne-Lawrence, J.M. Savitt, 
M. Lutter, and J.M. Zigman. 2011a. Ghrelin mediates stress- 
induced food-reward behavior in mice. J. Clin. Invest. 121:2684–
2692. http://dx.doi.org/10.1172/JCI57660
Chuang, J.C., I. Sakata, D. Kohno, M. Perello, S. Osborne-Lawrence, 
J.J. Repa, and J.M. Zigman. 2011b. Ghrelin directly stimulates 
glucagon secretion from pancreatic alpha-cells. Mol. Endocrinol. 
25:1600–1611. http://dx.doi.org/10.1210/me.2011-1001
Cogger, V.C., G.P. McNerney, T. Nyunt, L.D. DeLeve, P. McCourt, 
B. Smedsrød, D.G. Le Couteur, and T.R. Huser. 2010. Three-
dimensional structured illumination microscopy of liver sinu-
soidal endothelial cell fenestrations. J. Struct. Biol. 171:382–388. 
http://dx.doi.org/10.1016/j.jsb.2010.06.001
Cowley, M.A., R.G. Smith, S. Diano, M. Tschöp, N. Pronchuk, K.L. 
Grove, C.J. Strasburger, M. Bidlingmaier, M. Esterman, M.L. 
Heiman, et al. 2003. The distribution and mechanism of action of 
ghrelin in the CNS demonstrates a novel hypothalamic circuit regu-
lating energy homeostasis. Neuron. 37:649–661. http://dx.doi
.org/10.1016/S0896-6273(03)00063-1
Cui, R.J., X. Li, and S.M. Appleyard. 2011. Ghrelin inhibits visceral 
afferent activation of catecholamine neurons in the solitary tract 
nucleus. J. Neurosci. 31:3484–3492. http://dx.doi.org/10.1523/
JNEUROSCI.3187-10.2011
Diano, S., S.A. Farr, S.C. Benoit, E.C. McNay, I. da Silva, B. Horvath, 
F.S. Gaskin, N. Nonaka, L.B. Jaeger, W.A. Banks, et al. 2006. 
Ghrelin controls hippocampal spine synapse density and mem-
ory performance. Nat. Neurosci. 9:381–388. http://dx.doi.org/
10.1038/nn1656
Evron, T., S.M. Peterson, N.M. Urs, Y. Bai, L.K. Rochelle, M.G. 
Caron, and L.S. Barak. 2014. G Protein and -arrestin signal-
ing bias at the ghrelin receptor. J. Biol. Chem. 289:33442–33455. 
http://dx.doi.org/10.1074/jbc.M114.581397
Furness, J.B., B. Hunne, N. Matsuda, L. Yin, D. Russo, I. Kato, M. 
Fujimiya, M. Patterson, J. McLeod, Z.B. Andrews, and R. Bron. 
2011. Investigation of the presence of ghrelin in the central ner-
vous system of the rat and mouse. Neuroscience. 193:1–9. http://
dx.doi.org/10.1016/j.neuroscience.2011.07.063
Gamper, N., V. Reznikov, Y. Yamada, J. Yang, and M.S. Shapiro. 
2004. Phosphatidylinositol 4,5-bisphosphate signals underlie 
receptor-specific Gq/11-mediated modulation of N-type Ca2+ chan-
nels. J. Neurosci. 24:10980–10992. http://dx.doi.org/10.1523/
JNEUROSCI.3869-04.2004
2006) that are not accessed by plasma ghrelin (Cabral 
et al., 2013, 2014). It has been proposed that GHSR1a 
located in obviously inaccessible areas to plasma ghrelin 
could be modulated by centrally produced ghrelin 
(Cowley et al., 2003); however, more recent studies have 
clearly shown that ghrelin is not synthesized in the cen-
tral nervous system (Sakata et al., 2009; Furness et al., 
2011). Besides receptor expression levels, heterodimer-
ization of GHSR1a with other GPCRs could also serve 
as an alternative mechanism to modulate specific func-
tions of this receptor, independently of ghrelin binding 
(Jiang et al., 2006; Rediger et al., 2011; Kern et al., 2012; 
Schellekens et al., 2013). Thus, more efforts will be re-
quired to get insight on the complexity of the GHSR1a/
actions in neurons.
We thank Dr. Jeffrey Zigman for providing GHSR-GFP mice.
This work was supported by grants from the National Agency of 
Scientific and Technological Promotion of Argentina (PICT2010-
1954 and PICT2011-2142 to M. Perelló and PICT2011-1816 and 
PICT2013-1145 to J. Raingo) and National Institutes of Health 
(R03TW008925-01A1 to M. Perelló). E.J. López Soto, F. Agosti, 
A. Cabral, E.R. Mustafa, and V. Martínez Damonte were supported 
by National Scientific and Technical Research Council-Argentina 
and Comisión de Investigaciones Científicas fellowships.
The authors declare no competing financial interests.
Angus C. Nairn served as editor.
Submitted: 13 February 2015
Accepted: 13 July 2015
R E F E R ENC E S
Agosti, F., E.J. López Soto, A. Cabral, D. Castrogiovanni, H.B. 
Schioth, M. Perelló, and J. Raingo. 2014. Melanocortin 4 receptor 
activation inhibits presynaptic N-type calcium channels in amyg-
daloid complex neurons. Eur. J. Neurosci. 40:2755–2765. http://
dx.doi.org/10.1111/ejn.12650
Altier, C., H. Khosravani, R.M. Evans, S. Hameed, J.B. Peloquin, 
B.A. Vartian, L. Chen, A.M. Beedle, S.S. Ferguson, A. Mezghrani, 
et al. 2006. ORL1 receptor-mediated internalization of N-type cal-
cium channels. Nat. Neurosci. 9:31–40. http://dx.doi.org/10.1038/
nn1605
Andrews, Z.B., Z.W. Liu, N. Walllingford, D.M. Erion, E. Borok, 
J.M. Friedman, M.H. Tschöp, M. Shanabrough, G. Cline, G.I. 
Shulman, et al. 2008. UCP2 mediates ghrelin’s action on NPY/AgRP 
neurons by lowering free radicals. Nature. 454:846–851. http://
dx.doi.org/10.1038/nature07181
Andrews, Z.B., D. Erion, R. Beiler, Z.W. Liu, A. Abizaid, J. Zigman, 
J.D. Elsworth, J.M. Savitt, R. DiMarchi, M. Tschoep, et al. 2009. 
Ghrelin promotes and protects nigrostriatal dopamine function via a 
UCP2-dependent mitochondrial mechanism. J. Neurosci. 29:14057–
14065. http://dx.doi.org/10.1523/JNEUROSCI.3890-09.2009
Beedle, A.M., J.E. McRory, O. Poirot, C.J. Doering, C. Altier, C. 
Barrere, J. Hamid, J. Nargeot, E. Bourinet, and G.W. Zamponi. 
2004. Agonist-independent modulation of N-type calcium chan-
nels by ORL1 receptors. Nat. Neurosci. 7:118–125. http://dx.doi
.org/10.1038/nn1180
Bennett, K.A., C.J. Langmead, A. Wise, and G. Milligan. 2009. 
Growth hormone secretagogues and growth hormone releasing 
peptides act as orthosteric super-agonists but not allosteric regu-
lators for activation of the G protein Galpha(o1) by the Ghrelin 
218 Constitutive GHSR1a activation impairs CaV2 currents
calcium entry. Neuron. 58:557–570. http://dx.doi.org/10.1016/j.
neuron.2008.03.002
Kitano, J., M. Nishida, Y. Itsukaichi, I. Minami, M. Ogawa, T. Hirano, 
Y. Mori, and S. Nakanishi. 2003. Direct interaction and functional 
coupling between metabotropic glutamate receptor subtype 1 
and voltage-sensitive Cav2.1 Ca2+ channel. J. Biol. Chem. 278:25101–
25108. http://dx.doi.org/10.1074/jbc.M303266200
Kurrasch, D.M., J. Huang, T.M. Wilkie, and J.J. Repa. 2004. Quan-
titative real-time polymerase chain reaction measurement of 
regulators of G-protein signaling mRNA levels in mouse tissues. 
Methods Enzymol. 389:3–15. http://dx.doi.org/10.1016/S0076-
6879(04)89001-3
Lauckner, J.E., B. Hille, and K. Mackie. 2005. The cannabinoid 
agonist WIN55,212-2 increases intracellular calcium via CB1 re-
ceptor coupling to Gq/11 G proteins. Proc. Natl. Acad. Sci. USA. 
102:19144–19149. http://dx.doi.org/10.1073/pnas.0509588102
Lipscombe, D., S.E. Allen, and C.P. Toro. 2013. Control of neuro-
nal voltage-gated calcium ion channels from RNA to protein. 
Trends Neurosci. 36:598–609. http://dx.doi.org/10.1016/j.tins
.2013.06.008
Liu, G., J.P. Fortin, M. Beinborn, and A.S. Kopin. 2007. Four mis-
sense mutations in the ghrelin receptor result in distinct phar-
macological abnormalities. J. Pharmacol. Exp. Ther. 322:1036–1043. 
http://dx.doi.org/10.1124/jpet.107.123141
Liu, L., and A.R. Rittenhouse. 2003. Arachidonic acid mediates 
muscarinic inhibition and enhancement of N-type Ca2+ current 
in sympathetic neurons. Proc. Natl. Acad. Sci. USA. 100:295–300. 
http://dx.doi.org/10.1073/pnas.0136826100
Lopez Soto, E.J., and J. Raingo. 2012. A118G Mu Opioid Receptor 
polymorphism increases inhibitory effects on CaV2.2 channels. 
Neurosci. Lett. 523:190–194. http://dx.doi.org/10.1016/j.neulet
.2012.06.074
Mani, B.K., A.K. Walker, E.J. Lopez Soto, J. Raingo, C.E. Lee, M. 
Perelló, Z.B. Andrews, and J.M. Zigman. 2014. Neuroanatomical 
characterization of a growth hormone secretagogue receptor-green 
fluorescent protein reporter mouse. J. Comp. Neurol. 522:3644–
3666. http://dx.doi.org/10.1002/cne.23627
McGirr, R., M.S. McFarland, J. McTavish, L.G. Luyt, and S. Dhanvantari. 
2011. Design and characterization of a fluorescent ghrelin analog 
for imaging the growth hormone secretagogue receptor 1a. 
Regul. Pept. 172:69–76. http://dx.doi.org/10.1016/j.regpep.2011
.08.011
Nakazato, M., N. Murakami, Y. Date, M. Kojima, H. Matsuo, K. 
Kangawa, and S. Matsukura. 2001. A role for ghrelin in the central 
regulation of feeding. Nature. 409:194–198. http://dx.doi.org/
10.1038/35051587
Pantel, J., M. Legendre, S. Cabrol, L. Hilal, Y. Hajaji, S. Morisset, S. 
Nivot, M.P. Vie-Luton, D. Grouselle, M. de Kerdanet, et al. 2006. 
Loss of constitutive activity of the growth hormone secretagogue 
receptor in familial short stature. J. Clin. Invest. 116:760–768. 
http://dx.doi.org/10.1172/JCI25303
Paxinos, G., and K. Franklin. 2001. The Mouse Brain in Stereotaxic 
Coordinates. Second edition. Academic Press, Waltham, MA. 120 pp.
Petersen, P.S., D.P. Woldbye, A.N. Madsen, K.L. Egerod, C. Jin, M. 
Lang, M. Rasmussen, A.G. Beck-Sickinger, and B. Holst. 2009. 
In vivo characterization of high basal signaling from the ghre-
lin receptor. Endocrinology. 150:4920–4930. http://dx.doi.org/10
.1210/en.2008-1638
Raingo, J., A.J. Castiglioni, and D. Lipscombe. 2007. Alternative 
splicing controls G protein-dependent inhibition of N-type cal-
cium channels in nociceptors. Nat. Neurosci. 10:285–292. http://
dx.doi.org/10.1038/nn1848
Raingo, J., M. Khvotchev, P. Liu, F. Darios, Y.C. Li, D.M. Ramirez, M. 
Adachi, P. Lemieux, K. Toth, B. Davletov, and E.T. Kavalali. 2012. 
VAMP4 directs synaptic vesicles to a pool that selectively maintains 
Gandini, M.A., D.R. Henríquez, L. Grimaldo, A. Sandoval, C. Altier, 
G.W. Zamponi, R. Felix, and C. González-Billault. 2014. CaV2.2 
channel cell surface expression is regulated by the light chain 
1 (LC1) of the microtubule-associated protein B (MAP1B) via 
UBE2L3-mediated ubiquitination and degradation. Pflugers Arch. 
466:2113–2126. http://dx.doi.org/10.1007/s00424-014-1476-4
Heneghan, J.F., T. Mitra-Ganguli, L.F. Stanish, L. Liu, R. Zhao, and 
A.R. Rittenhouse. 2009. The Ca2+ channel  subunit determines 
whether stimulation of Gq-coupled receptors enhances or inhib-
its N current. J. Gen. Physiol. 134:369–384. http://dx.doi.org/10
.1085/jgp.200910203
Holst, B., A. Cygankiewicz, T.H. Jensen, M. Ankersen, and T.W. 
Schwartz. 2003. High constitutive signaling of the ghrelin recep-
tor—identification of a potent inverse agonist. Mol. Endocrinol. 
17:2201–2210. http://dx.doi.org/10.1210/me.2003-0069
Howard, A.D., S.D. Feighner, D.F. Cully, J.P. Arena, P.A. Liberator, 
C.I. Rosenblum, M. Hamelin, D.L. Hreniuk, O.C. Palyha, J. 
Anderson, et al. 1996. A receptor in pituitary and hypothalamus 
that functions in growth hormone release. Science. 273:974–977. 
http://dx.doi.org/10.1126/science.273.5277.974
Ikeda, S.R. 1996. Voltage-dependent modulation of N-type calcium 
channels by G-protein beta gamma subunits. Nature. 380:255–258. 
http://dx.doi.org/10.1038/380255a0
Jiang, H., L. Betancourt, and R.G. Smith. 2006. Ghrelin amplifies 
dopamine signaling by cross talk involving formation of growth 
hormone secretagogue receptor/dopamine receptor subtype 1 
heterodimers. Mol. Endocrinol. 20:1772–1785. http://dx.doi.org/
10.1210/me.2005-0084
Jiang, M., and G. Chen. 2006. High Ca2+-phosphate transfection ef-
ficiency in low-density neuronal cultures. Nat. Protoc. 1:695–700. 
http://dx.doi.org/10.1038/nprot.2006.86
Kammermeier, P.J., and S.R. Ikeda. 1999. Expression of RGS2 alters 
the coupling of metabotropic glutamate receptor 1a to M-type K+ 
and N-type Ca2+ channels. Neuron. 22:819–829. http://dx.doi.org/
10.1016/S0896-6273(00)80740-0
Kammermeier, P.J., V. Ruiz-Velasco, and S.R. Ikeda. 2000. A voltage-
independent calcium current inhibitory pathway activated by mus-
carinic agonists in rat sympathetic neurons requires both Galpha 
q/11 and Gbeta gamma. J. Neurosci. 20:5623–5629.
Kern, A., R. Albarran-Zeckler, H.E. Walsh, and R.G. Smith. 2012. 
Apo-ghrelin receptor forms heteromers with DRD2 in hypotha-
lamic neurons and is essential for anorexigenic effects of DRD2 ag-
onism. Neuron. 73:317–332. http://dx.doi.org/10.1016/j.neuron
.2011.10.038
Keum, D., C. Baek, D.I. Kim, H.J. Kweon, and B.C. Suh. 2014. Voltage-
dependent regulation of CaV2.2 channels by Gq-coupled recep-
tor is facilitated by membrane-localized  subunit. J. Gen. Physiol. 
144:297–309. http://dx.doi.org/10.1085/jgp.201411245
Kim, M.S., C.Y. Yoon, K.H. Park, C.S. Shin, K.S. Park, S.Y. Kim, B.Y. 
Cho, and H.K. Lee. 2003. Changes in ghrelin and ghrelin receptor 
expression according to feeding status. Neuroreport. 14:1317–1320.
Kineman, R.D., and R.M. Luque. 2007. Evidence that ghrelin is 
as potent as growth hormone (GH)-releasing hormone (GHRH) 
in releasing GH from primary pituitary cell cultures of a nonhu-
man primate (Papio anubis), acting through intracellular signal-
ing pathways distinct from GHRH. Endocrinology. 148:4440–4449. 
http://dx.doi.org/10.1210/en.2007-0441
Kisilevsky, A.E., and G.W. Zamponi. 2008. D2 dopamine receptors 
interact directly with N-type calcium channels and regulate chan-
nel surface expression levels. Channels (Austin). 2:269–277. http://
dx.doi.org/10.4161/chan.2.4.6402
Kisilevsky, A.E., S.J. Mulligan, C. Altier, M.C. Iftinca, D. Varela, C. 
Tai, L. Chen, S. Hameed, J. Hamid, B.A. Macvicar, and G.W. 
Zamponi. 2008. D1 receptors physically interact with N-type cal-
cium channels to regulate channel distribution and dendritic 
 López Soto et al. 219
asynchronous neurotransmission. Nat. Neurosci. 15:738–745. http://
dx.doi.org/10.1038/nn.3067
Rediger, A., C.L. Piechowski, C.X. Yi, P. Tarnow, R. Strotmann, A. 
Grüters, H. Krude, T. Schöneberg, M.H. Tschöp, G. Kleinau, and 
H. Biebermann. 2011. Mutually opposite signal modulation by 
hypothalamic heterodimerization of ghrelin and melanocortin-3 
receptors. J. Biol. Chem. 286:39623–39631. http://dx.doi.org/10
.1074/jbc.M111.287607
Ribeiro, L.F., T. Catarino, S.D. Santos, M. Benoist, J.F. van Leeuwen, 
J.A. Esteban, and A.L. Carvalho. 2014. Ghrelin triggers the synap-
tic incorporation of AMPA receptors in the hippocampus. Proc. 
Natl. Acad. Sci. USA. 111:E149–E158. http://dx.doi.org/10.1073/
pnas.1313798111
Sakata, I., Y. Nakano, S. Osborne-Lawrence, S.A. Rovinsky, C.E. Lee, 
M. Perello, J.G. Anderson, R. Coppari, G. Xiao, B.B. Lowell, et al.  
2009. Characterization of a novel ghrelin cell reporter mouse. 
Regul. Pept. 155:91–98. http://dx.doi.org/10.1016/j.regpep.2009
.04.001
Schaeffer, M., F. Langlet, C. Lafont, F. Molino, D.J. Hodson, T. 
Roux, L. Lamarque, P. Verdié, E. Bourrier, B. Dehouck, et al. 
2013. Rapid sensing of circulating ghrelin by hypothalamic appe-
tite-modifying neurons. Proc. Natl. Acad. Sci. USA. 110:1512–1517. 
http://dx.doi.org/10.1073/pnas.1212137110
Schellekens, H., W.E. van Oeffelen, T.G. Dinan, and J.F. Cryan. 2013. 
Promiscuous dimerization of the growth hormone secretagogue 
receptor (GHS-R1a) attenuates ghrelin-mediated signaling. J. Biol. 
Chem. 288:181–191. http://dx.doi.org/10.1074/jbc.M112.382473
Shi, L., X. Bian, Z. Qu, Z. Ma, Y. Zhou, K. Wang, H. Jiang, and J. Xie. 
2013. Peptide hormone ghrelin enhances neuronal excitability 
by inhibition of Kv7/KCNQ channels. Nat. Commun. 4:1435. 
http://dx.doi.org/10.1038/ncomms2439
Suh, B.C., K. Leal, and B. Hille. 2010. Modulation of high-voltage 
activated Ca2+ channels by membrane phosphatidylinositol 4,5-
bisphosphate. Neuron. 67:224–238. http://dx.doi.org/10.1016/j
.neuron.2010.07.001
Suh, B.C., D.I. Kim, B.H. Falkenburger, and B. Hille. 2012. Membrane- 
localized -subunits alter the PIP2 regulation of high-voltage ac-
tivated Ca2+ channels. Proc. Natl. Acad. Sci. USA. 109:3161–3166. 
http://dx.doi.org/10.1073/pnas.1121434109
Tong, Q., C.P. Ye, J.E. Jones, J.K. Elmquist, and B.B. Lowell. 2008. 
Synaptic release of GABA by AgRP neurons is required for nor-
mal regulation of energy balance. Nat. Neurosci. 11:998–1000. 
http://dx.doi.org/10.1038/nn.2167
Uchida, A., J.M. Zigman, and M. Perelló. 2013. Ghrelin and eat-
ing behavior: evidence and insights from genetically-modified 
mouse models. Front Neurosci. 7:121. http://dx.doi.org/10.3389/
fnins.2013.00121
Wu, L., C.S. Bauer, X.G. Zhen, C. Xie, and J. Yang. 2002. Dual 
regulation of voltage-gated calcium channels by PtdIns(4,5)P2. 
Nature. 419:947–952. http://dx.doi.org/10.1038/nature01118
Wu, Q., M.P. Boyle, and R.D. Palmiter. 2009. Loss of GABAergic 
signaling by AgRP neurons to the parabrachial nucleus leads to 
starvation. Cell. 137:1225–1234. http://dx.doi.org/10.1016/j.cell
.2009.04.022
Yang, Y., D. Atasoy, H.H. Su, and S.M. Sternson. 2011. Hunger states 
switch a flip-flop memory circuit via a synaptic AMPK-dependent 
positive feedback loop. Cell. 146:992–1003. http://dx.doi.org/10
.1016/j.cell.2011.07.039
Yu, B., and M.I. Simon. 1998. Interaction of the xanthine nucleo-
tide binding Goalpha mutant with G protein-coupled receptors. 
J. Biol. Chem. 273:30183–30188. http://dx.doi.org/10.1074/jbc
.273.46.30183
Zamponi, G.W., and K.P. Currie. 2013. Regulation of CaV2 calcium 
channels by G protein coupled receptors. Biochim. Biophys. Acta. 
1828:1629–1643. http://dx.doi.org/10.1016/j.bbamem.2012.10 
.004
Zigman, J.M., J.E. Jones, C.E. Lee, C.B. Saper, and J.K. Elmquist. 
2006. Expression of ghrelin receptor mRNA in the rat and the 
mouse brain. J. Comp. Neurol. 494:528–548. http://dx.doi.org/10
.1002/cne.20823
